SENSEX    72943.68       -456.10    |    NIFTY    22147.9       -124.60 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Shree Cement in focus after Q4 result
20-May-19   08:38 Hrs IST

Shree Cement's net profit fell 19.61% to Rs 320.95 crore on 14.2% rise in total income to Rs 3329.96 crore in Q4 March 2019 over Q4 March 2018. The result was announced on Saturday, 18 May 2019.

Engineers India net profit rose 37.7% to Rs 94.90 crore on 20.55% rise in total income to Rs 672.21 crore in Q4 March 2019 over Q4 March 2018. The result was announced after market hours on Friday, 17 May 2019.

Bharat Petroleum Corporation, Hindustan Petroleum Corporation and Tata Motors will announce January-March 2019 quarterly earnings today, 20 May 2019.

Cipla informed that the United States Food and Drug Administration (USFDA) conducted a post-approval inspection at our Indore facility from 13 May to 17 May 2019. The inspection ended with zero observations. The announcement was made after market hours on Friday, 17 May 2019.

Alkem Laboratories said that US FDA had conducted an inspection at the company's manufacturing facility located at Baddi from 13 May 2019 to 17 May 2019. At the end of the inspection, the company has received a Form 483 with four observations. The company shall put together a detailed response with adequate corrective and preventive measures to address the US FDA observations and the same is proposed to be filed within the timeline stipulated by US FDA. The announcement was made after market hours on Friday, 17 May 2019.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.85 88.96 1.06
United Kingdom (GBP) 1.17 1.00 104.08 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.80 83.61 1.00
Market News << ALL News
  16-Apr-2024, (03:45 )  Sasken Tech rises af..
  16-Apr-2024, (03:34 )  CRISIL slides after ..
  16-Apr-2024, (03:34 )  J&K Bank appoints Fa..
  16-Apr-2024, (03:00 )  KEI Industries Ltd l..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)